{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "SARS-CoV-2",
      "drugs"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "32614684",
  "DateCompleted": {
    "Year": "2021",
    "Month": "06",
    "Day": "30"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "07",
        "Day": "02"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1089/vim.2020.0027"
    ],
    "Journal": {
      "ISSN": "1557-8976",
      "JournalIssue": {
        "Volume": "34",
        "Issue": "5",
        "PubDate": {
          "Year": "2021",
          "Month": "Jun"
        }
      },
      "Title": "Viral immunology",
      "ISOAbbreviation": "Viral Immunol"
    },
    "ArticleTitle": "Review of the SARS-CoV-2 in Wuhan and Analysis as Well as Prediction of Therapeutic Drugs.",
    "Pagination": {
      "StartPage": "291",
      "EndPage": "299",
      "MedlinePgn": "291-299"
    },
    "Abstract": {
      "AbstractText": [
        "Due to the worldwide impact of SARS-CoV-2, people have carried out in-depth research on the virus to fight against this highly contagious disease. In this article, many articles published recently are summarized vertically, from the structure and sites of SARS-Cov-2, the mode of transmission, the mathematical model of transmission, the mechanism of the virus itself, the symptoms of patients after infection to medicine used in the early stage period and the prediction as well the analysis of probability in using new medicine."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "China Medical University-Queen Belfast Joint College, Shenyang, China."
          }
        ],
        "LastName": "Zhang",
        "ForeName": "Ruiyi",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Gynecology, Zhongshan Hospital, Dalian University, Dalian, China."
          }
        ],
        "LastName": "Tang",
        "ForeName": "Yanmei",
        "Initials": "Y"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Viral Immunol",
    "NlmUniqueID": "8801552",
    "ISSNLinking": "0882-8245"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "epidemiology",
        "transmission"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "China"
    },
    {
      "QualifierName": [
        "virology"
      ],
      "DescriptorName": "Chiroptera"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Global Health"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "chemistry",
        "drug effects",
        "genetics",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ]
}